Hyponatremia: all 156 studies

Page 2 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetics and Clinical Response of Tolvaptan in Neurocritical Care PatientsTerminatedNCT02215148
• Effects of Oral Salt Supplementation on Physical Performance During a Half-ironmanCompletedNCT02103491Not applicable
• Relationship Between Heat Wave and HyponatremiaCompletedNCT02012660
• Characterisation of Neuropsychological and Motoric Performance in Patients With HyponatremiaCompletedNCT01879774Not applicable
• Efficacy and Safety of Tolvaptan in Cirrhotic Patients With HyponatremiaCompletedNCT01850940
• Bioimpedance Spectroscopy for the Differential Diagnosis of HyponatremiaCompletedNCT01838759
• The Effect of Fluid Restriction in Congestive Heart Failure Complicated With HyponatremiaStatus unknownNCT01748331Not applicable
• Tolvaptan for Hyponatremia in Cirrhotic Patients With AscitesStatus unknownNCT01716611Phase 4
• Hyponatremia and Myometrium Contractility. An Invitro StudyTerminatedNCT01708811
• Effect of Tolvaptan on Cognitive Function in CirrhosisCompletedNCT01556646Phase 3
• Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With AscitesTerminatedNCT01552590Phase 4
• The Clinical and Laboratory Characteristics of Recurrent Drug- Related HyponatremiaStatus unknownNCT01509170
• Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaStatus unknownNCT01507727Phase 2/3
• Post Operative Hyponatremia in the Renal Transplant PopulationCompletedNCT01456832
• Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized PatientsCompletedNCT01456533
• Pseudohyponatremia of Multiple Myeloma is True HyponatremiaStatus unknownNCT01425606
• Fractional Urate Excretion in Nonedematous HyponatremiaWithdrawnNCT01425125Not applicable
• Tolvaptan for In-hospital HyponatremiaTerminatedNCT01386372Phase 2
• Institutional Registry of HyponatremiaCompletedNCT01370473
• Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of HyponatremiaCompletedNCT01346891
• Subclassification of the Syndrome of Inappropriate ADH SecretionCompletedNCT01341665
• Frequency and Origin of Dysnatremias in the Emergency DepartmentWithdrawnNCT01326429
• Incidence of Hyponatremia in PEG-SD Compared to PEG-ELSCompletedNCT01299779Not applicable
• Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNCT01240668
• Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeStatus unknownNCT01228682
• Radiocontrast Media Induced HyponatremiaStatus unknownNCT01219270
• Hyponatremia in the Elderly: Benefit From a Change in Drug Therapy?CompletedNCT01212211Not applicable
• The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated HyponatremiaStatus unknownNCT01110655Not applicable
• International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430CompletedNCT01056848
• Do Changes in Plasma Osmolality Influence Ventilation?CompletedNCT01008644Early Phase 1
• Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney FunctionCompletedNCT00887627Phase 1
• Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status ChangesCompletedNCT00885430Phase 4
• International, Multicenter, Open-Label and Randomized Withdrawal Study of Oral Lixivaptan in Heart Failure Patients With Chronic HyponatremiaWithdrawnNCT00876876Phase 3
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic HyponatremiaCompletedNCT00876798Phase 3
• Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver FunctionCompletedNCT00851227Phase 1
• Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver TransplantationCompletedNCT00839358Phase 4
• A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaTerminatedNCT00728091Phase 3
• Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological PatientsWithdrawnNCT00684164Phase 3
• A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaCompletedNCT00664014Phase 2
• Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic HyponatremiaCompletedNCT00660959Phase 3
• Postoperative Hyponatremia - Are There Gender Differences?Status unknownNCT00636857Not applicable
• 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Hospitalized ChildrenCompletedNCT00632775Phase 3
• The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium ConcentrationCompletedNCT00589134Not applicable
• THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient EvaluationCompletedNCT00578695Phase 3
• Hypertonic Saline Solution in Heart FailureCompletedNCT00555685Phase 2
• Establishment of an Algorithm for a Clinical Classfication of Hypoosmolar HyponatremiaCompletedNCT00541944
• Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00492037Phase 3
• Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00380575Phase 3
• An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00379847Phase 3
• DILIPO (DILutIonal HyPOnatremia)CompletedNCT00274326Phase 3
• Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNCT00264927Phase 3
• Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNCT00264914Phase 3
• Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00201994Phase 3
• Management of Hyponatremia in Preterm Infants on DiureticsTerminatedNCT00156572Phase 3
• "SALT Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNCT00072683Phase 3
• Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCompletedNCT00032734Phase 2

← Hyponatremia overview